Source: International Congress 2018 – Biomarkers and lung function in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bialas (Lodz, Poland), K. Kornicki (Lodz, Poland), M. Ciebiada (Lodz, Poland), J. Milkowska - Dymanowska (Lodz, Poland), W. Piotrowski (Lodz, Poland), A. Antczak (Lodz, Poland), P. Gorski (Lodz, Poland). FEV1/FEV3 ratio as an alternative to fixed ratio of FEV1/FVC. 5058

Member's Comments

No comment yet.

Related content which might interest you: FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 FEV1/FVC and FEV1/FEV6 in 8776 patients with normal lung function or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 715s Year: 2005 FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 FEV1/FEV3 ratio: a potential alternative to full spirometry for patients unable to sustain forced expiration? Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 The effect of stop smoking on FEV1 and FEV1/FVC Source: Eur Respir J 2003; 22: Suppl. 45, 307s Year: 2003 Fixed ratio or LLN for defining airflow obstruction in population screening Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011 Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1 Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function Year: 2016 Asthma control and decline in FEV1/FVC ratio over 10 years in adults Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio Source: Eur Respir J 2007; 30: Suppl. 51, 744s Year: 2007 Midflows do not vary independently of FEV1 and FVC Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 Comparative study of FEV1/FVC and FEV1/FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005 Assessment of the relationship between FEF25-75/FVC ratio and reversibility in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Reference values for FEV1, FVC and FEV1/FVC in Norway Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 FEV6 as an alternative for FVC in predicting airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 220s Year: 2006 GOLD and the fixed ratio Source: Eur Respir J 2011; 38: 481-482 Year: 2011